Authors
Latest:
Predictive Factors of Discharge Navigation Lag TimeExamination of factors associated with discharge lag time and how this metric plays an important role in managing hospital throughput.
Latest:
Cost Minimization of Medicare Part D Prescription Drug Plan ExpendituresStudy results indicate that outreach interventions performed by trained student pharmacists assist Medicare beneficiaries to effectively navigate their Part D benefit, thereby reducing out-of-pocket costs.
Latest:
Analyzing Admission Rates for Multiple Ambulatory Care–Sensitive ConditionsAmbulatory care–sensitive conditions can be systematically assessed in a large electronic medical database to describe admission rates by year, catchment area, and hospital affiliation.
Latest:
CHAPTER 5. Clinical Guideline for Pharmacological Management of Adults With Type 2 DiabetesFrom the Adult Diabetes and Clinical Research Sections, Joslin Diabetes Center, Harvard Medical School. Approved May 10, 2016; updated April 24, 2018. For the Figure and Tables, download the PDF at the end of the chapter.
Latest:
Synchronized Prescription Refills and Medication Adherence: A Retrospective Claims AnalysisA retrospective claims analysis showed that synchronized refill schedules were associated with better medication adherence among Medicare Advantage patients taking multiple maintenance medications.
Latest:
Medicare Part D Coverage Gap and Diabetes BeneficiariesWhen diabetic patients in 2 Medicare Advantage Part D plans reached the 2006 coverage gap, overall drug costs dropped as out-of-pocket costs increased.
Latest:
Electronic Health Record Availability Among Advanced Practice Registered Nurses and PhysiciansAvailability of electronic health records among advanced practice nurses and physicians in California is concentrated among large practices with fewer Medicaid patients.
Latest:
A Machine Learning Technology for Addressing Medication-Related Risk in Older, Multimorbid PatientsA novel machine learning system effectively stratifies emergency department use and hospitalization risk of older patients with multimorbidity who take multiple medications and provides appropriate medication recommendations.
Latest:
Impact of a National Specialty E-Consultation Implementation Project on AccessE-consult implementation grew from 12 to 122 VHA sites with multiple specialties. The adjusted e-consult rate of 1.93/100 consults saved significant patient travel miles and costs.
Latest:
Influence of Patient Preferences on the Cost-Effectiveness of Screening for Lynch SyndromeThis cost-utility analysis reports on the effect of quality of life on the value of screening all new patients with colorectal cancer for Lynch Syndrome.
Latest:
Use of Postacute Care After Discharge in Urban and Rural HospitalsRural patients receive less postacute care after hospital discharge than urban patients, especially after elective joint replacement-a condition selected for bundled payments.
Latest:
Pediatric Integrated Delivery System's Experience With Pandemic Influenza A (H1N1)Experience of a pediatric integrated delivery system with the surge from the 2009 H1N1 pandemic is described, emphasizing scale, scope, and flexibility at multiple locations.
Latest:
Cost-Effectiveness of the MiniMed 780G System for Type 1 DiabetesA new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments.
Latest:
Reconsidering the Economic Value of Multiple Sclerosis TherapiesAvailability of multiple sclerosis (MS) therapies provides substantial value to the currently healthy (who may contract MS in the future), particularly when treatment is fully covered by insurance.
Latest:
A Strategic Plan for Integrating Cost-effectiveness Analysis Into the US Healthcare SystemA panel composed of medical and pharmacy directors expressed strong support for a greater role for cost-effectiveness analysis in US health policy decisions.
Latest:
Trends in Viral Hepatitis Cost-Effectiveness StudiesRegardless of the cause of bias, more awareness and scrutiny are needed when utilizing cost-effectiveness studies for healthcare decision making.
Latest:
Limited Distribution Networks Stifle Competition in the Generic and Biosimilar Drug IndustriesA limited distribution network is a pharmaceutical distribution strategy that some drug companies have capitalized upon to obstruct generic and biosimilar competition.
